APR 09, 2020 4:36 PM PDT

Adjuvant immunotherapy proves effective for colon cancer

Results from a study published in Nature Medicine highlights the benefits of receiving pre-surgery immunotherapy for some types of colon cancer. The NICHE study was carried out by scientists at the Netherlands Cancer Institute and found that 100% of patients in a phase II clinical trial with MSI colon cancer benefited from immunotherapy pre-surgery, while 25% of MSS colon cancer patients saw benefits.

Pre-surgery immunotherapy, also known as neoadjuvant immunotherapy, is meant to keep cancer from metastasizing while also giving the immune system a head-start to recognize tumor variations. Ideally, this allows the immune system a better opportunity to respond once the tumor is removed by surgery.

While the researchers conducting the clinical trials hoped for positive results, they say they were blown away with their findings. 'A good response rate was on the cards in this group', says oncologist and project manager Myriam Chalabi. 'But a 100% rate is unprecedented. You don't dare hope it will be that good.'

Participating in the study were 40 patients with two different colon cancer subtypes: microsatellite-instable (MSI) tumors and microsatellite-stable (MSS) tumors. MSI means that the tumor is very susceptible to mutation; this subtype of colon cancer typically responds well to immunotherapy and the researchers showed that 100% of the patients responded well. MSS, on the other hand, does not typically respond well to immunotherapy; however, the researchers showed that 25% of the group responded well to adjuvant immunotherapy.

The researchers wanted to understand these unexpectedly positive results for MSS. “We looked at all the usual suspects, but they weren't the cause', says Chalabi. “We didn't see the same predictive factors as in melanoma, for instance. But in the end, we did find a new biomarker. If that proves to be predictive in follow-up studies, it could provide a simple way of identifying patients with MSS tumors who could benefit from immunotherapy.”

Photo: Pixabay

The researchers at the Netherlands Cancer Institute had previously shown in past studies that neoadjuvant immunotherapy has similar success outcomes for melanoma; they are simultaneously carrying out investigation on other types of tumors, as well. The researchers plan to continue monitoring the patients already involved in the colon cancer study for a minimum of three more years, in addition to increasing the number of patients involved. 'Only then can the new therapy be considered as a standard treatment', says Chalabi.

Sources: Nature Medicine, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 05, 2021
Cannabis Sciences
Can Smoking Cannabis Cause Lung Cancer?
APR 05, 2021
Can Smoking Cannabis Cause Lung Cancer?
So far, there is no firm consensus on whether smoking cannabis can cause lung cancer. As cannabis smoke contains many si ...
APR 25, 2021
Genetics & Genomics
How Did the Chernobyl Disaster Affect Human Health?
APR 25, 2021
How Did the Chernobyl Disaster Affect Human Health?
It's been about 35 years since the disaster at the Chernobyl nuclear power plant. Now researchers have investigated whet ...
JUN 07, 2021
Cancer
Inflammatory-rich diet associated with greater risk of developing breast cancer
JUN 07, 2021
Inflammatory-rich diet associated with greater risk of developing breast cancer
A breakthrough study soon to be presented at NUTRITION 2021 LIVE ONLINE later this week reports that women who main ...
JUN 14, 2021
Cell & Molecular Biology
Can An Omega-3 Fatty Acid Destroy Tumors?
JUN 14, 2021
Can An Omega-3 Fatty Acid Destroy Tumors?
The body needs fatty acts for a variety of functions, and the health benefits of taking fatty acid supplements have long ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
Loading Comments...